Eagle Health Investments LP - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eagle Health Investments LP ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,145,000
-24.7%
47,2000.0%0.28%
-23.8%
Q4 2021$1,520,000
-27.9%
47,2000.0%0.37%
-44.7%
Q3 2021$2,109,000
+18.1%
47,2000.0%0.67%
+9.1%
Q2 2021$1,786,00047,2000.61%
Other shareholders
C4 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,642,210$14,402,0001.72%
Soleus Capital Management, L.P. 1,441,513$12,642,0001.72%
Nextech Invest Ltd. 375,857$3,296,0001.06%
RTW INVESTMENTS, LP 2,819,472$24,727,0000.57%
ArrowMark Colorado Holdings LLC 5,091,975$44,657,0000.55%
WASATCH ADVISORS LP 5,934,476$52,045,0000.36%
HARBOR CAPITAL ADVISORS, INC. 25,470$223,0000.20%
Perceptive Advisors 766,231$6,720,0000.20%
DRIEHAUS CAPITAL MANAGEMENT LLC 606,721$5,321,0000.08%
Virtus ETF Advisers LLC 19,305$169,0000.07%
View complete list of C4 THERAPEUTICS INC shareholders